Element Research Group

San Antonio, Texas 78258

2 studies enrolling now · 13 studies all time

What they study most

Alpha1-antitrypsin Deficiency, Asthma, Bronchiectasis, COPD, Cardiovascular Disease, Chronic Obstructive Pulmonary Disease, Diabetic Foot Ulcer, Diabetic Foot Ulcer (DFU), Lower Extremity, OSA, Plantar Fasciitis, Severe Asthma

Studies at this site

• The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
• Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS — Recruiting now
• Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers — Recruiting now
• A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD — Running, not enrolling
• Registry of Asthma Patients Initiating DUPIXENT® — Completed
• A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT) — Completed
• Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) — Completed
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD — Completed
• Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis — Completed
• PriMatrix for the Management of Diabetic Foot Ulcers — Completed
• Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency — Stopped early
• Cardiovascular Inflammation Reduction Trial — Completed